TVTXTravere Therapeutics, Inc.
65.71USD-0.38%Mkt Cap: 6.11B $P/E: —3d ago
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap6.11B $
Enterprise Value6.20B $
Revenue (TTM)591.33M $
Gross Profit480.39M $
Net Income (TTM)-25.55M $
Revenue/Share6.482 USD
Last Price65.71 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees497
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)11.36
PEG—
EV/EBITDA270.75
EV/Revenue10.49
P/S10.28
P/B247.92
EPS (TTM)-0.72
EPS (Forward)5.67
52W Range
17.0599% of range66.38
52W High66.38 USD
52W Low17.05 USD
Profitability
Gross Margin97.89%
Oper. Margin2.33%
EBITDA Margin3.88%
Profit Margin-5.21%
ROE-22.25%
ROA-4.22%
Growth
Revenue Growth48.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF37.78M $
CapEx (TTM)58.16M $
FCF Margin-3.09%
FCF Yield-0.30%
Net Debt127.73M $
Net Debt/EBITDA5.57
Balance Sheet
Debt/Equity2.86
Current Ratio4.05
Quick Ratio3.76
Book Value/Sh0.2600 USD
Cash/Share5.190 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)74.14 USD
Upside (mean)+12.8%
Target Range62.00 USD – 90.00 USD
$62.00+12.8% to mean$90.00
# Analysts14
Ownership
Shares Out.92.99M
Float93.15M
Insiders0.79%
Institutions115.02%
Short Interest
Short Ratio8.7d
Short % Float16.13%
Short % Out.12.39%
Shares Short11.68M
Short (prev mo.)12.69M
Technical
SMA 5057.52 (+14.2%)
SMA 20040.66 (+61.6%)
Beta1.04
S&P 52W Chg18.16%
Avg Vol (30d)1.47M
Avg Vol (10d)1.28M
Technical Indicators
RSI (14)69.7
MACD2.4060
MACD Signal1.8937
MACD Hist.+0.5123
BB Upper66.82 USD
BB Middle59.75 USD
BB Lower52.67 USD
BB Width23.67%
ATR (14)2.671 USD
Vol Ratio (20d)0.89x